Vcanbio Cell & Gene Engineering Corp Ltd - Asset Resilience Ratio

Latest as of March 2026: 2.86%

Vcanbio Cell & Gene Engineering Corp Ltd (600645) has an Asset Resilience Ratio of 2.86% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥150.61 Million

≈ $22.04 Million USD Cash + Short-term Investments

Total Assets

CN¥5.27 Billion

≈ $770.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1996–2025)

This chart shows how Vcanbio Cell & Gene Engineering Corp Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Vcanbio Cell & Gene Engineering Corp Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Vcanbio Cell & Gene Engineering Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600645 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥150.61 Million	2.86%
Total Liquid Assets	CN¥150.61 Million	2.86%

Asset Resilience Insights

Limited Liquidity: Vcanbio Cell & Gene Engineering Corp Ltd maintains only 2.86% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Vcanbio Cell & Gene Engineering Corp Ltd Industry Peers by Asset Resilience Ratio

Compare Vcanbio Cell & Gene Engineering Corp Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Prostemics Co. Ltd KQ:203690	Biotechnology	0.31%
ORUM KQ:475830	Biotechnology	82.74%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
TG Therapeutics Inc NASDAQ:TGTX	Biotechnology	4.72%
Green Cross Holdings Preference Shares KO:005257	Biotechnology	0.50%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	33.70%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Cybin Inc NEO:CYBN	Biotechnology	0.21%

Annual Asset Resilience Ratio for Vcanbio Cell & Gene Engineering Corp Ltd (1996–2025)

The table below shows the annual Asset Resilience Ratio data for Vcanbio Cell & Gene Engineering Corp Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.45%	CN¥712.05 Million ≈ $104.20 Million	CN¥5.29 Billion ≈ $774.42 Million	+5.24pp
2019-12-31	8.22%	CN¥401.67 Million ≈ $58.78 Million	CN¥4.89 Billion ≈ $715.35 Million	+7.75pp
2017-12-31	0.47%	CN¥14.00 Million ≈ $2.05 Million	CN¥3.00 Billion ≈ $438.99 Million	-3.83pp
2016-12-31	4.30%	CN¥129.10 Million ≈ $18.89 Million	CN¥3.00 Billion ≈ $439.53 Million	+4.30pp
2015-12-31	0.00%	CN¥4.25K ≈ $621.91	CN¥2.82 Billion ≈ $412.09 Million	-15.20pp
2014-12-31	15.20%	CN¥367.39 Million ≈ $53.76 Million	CN¥2.42 Billion ≈ $353.67 Million	+9.70pp
2010-12-31	5.50%	CN¥42.45 Million ≈ $6.21 Million	CN¥771.69 Million ≈ $112.92 Million	+0.65pp
2008-12-31	4.85%	CN¥31.61 Million ≈ $4.63 Million	CN¥651.74 Million ≈ $95.37 Million	+1.13pp
2007-12-31	3.72%	CN¥21.90 Million ≈ $3.20 Million	CN¥588.65 Million ≈ $86.14 Million	+3.71pp
2006-12-31	0.01%	CN¥50.00K ≈ $7.32K	CN¥579.39 Million ≈ $84.78 Million	-0.22pp
2003-12-31	0.23%	CN¥1.45 Million ≈ $212.24K	CN¥636.09 Million ≈ $93.08 Million	-0.12pp
2002-12-31	0.35%	CN¥1.99 Million ≈ $290.86K	CN¥567.42 Million ≈ $83.03 Million	-3.41pp
2001-12-31	3.76%	CN¥29.35 Million ≈ $4.30 Million	CN¥781.36 Million ≈ $114.34 Million	-1.47pp
2000-12-31	5.23%	CN¥35.45 Million ≈ $5.19 Million	CN¥678.36 Million ≈ $99.26 Million	+1.14pp
1999-12-31	4.09%	CN¥26.97 Million ≈ $3.95 Million	CN¥659.36 Million ≈ $96.49 Million	+2.53pp
1998-12-31	1.56%	CN¥10.50 Million ≈ $1.54 Million	CN¥673.16 Million ≈ $98.50 Million	+0.67pp
1997-12-31	0.89%	CN¥5.37 Million ≈ $785.60K	CN¥606.51 Million ≈ $88.75 Million	-1.47pp
1996-12-31	2.36%	CN¥10.17 Million ≈ $1.49 Million	CN¥431.22 Million ≈ $63.10 Million	--

pp = percentage points

About Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology

Market Cap

$1.29 Billion

CN¥8.83 Billion CNY

Market Cap Rank

#7799 Global

#1759 in China

Share Price

CN¥18.87

Change (1 day)

-0.42%

52-Week Range

CN¥16.74 - CN¥32.94

All Time High

CN¥68.93